2025 AHA ACC JACC

Описание: “2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/
NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults”

—was published in JACC on August 14, 2025. It updates the 2017 version and reflects the latest evidence across multiple domains of hypertension care. Here's a structured summary tailored for your educational and clinical use:

🧠 Key Updates and Concepts

1. Risk Assessment
PREVENT™ Risk Calculator replaces pooled cohort equations.
Incorporates cardiovascular, kidney, and metabolic health.
Threshold for initiating therapy: ≥7.5% 10-year CVD risk.

2. Treatment Initiation
Stage 2 Hypertension (≥140/90 mm Hg): Start with two medications, preferably in a single-pill combination.
Stage 1 Hypertension (130–139/80–89 mm Hg): Treat if clinical CVD, CKD, diabetes, or PREVENT risk ≥7.5%.

3. Lifestyle and Psychosocial Interventions
Emphasis on team-based care, stress management, and addressing social determinants of health.

4. Special Populations
Pregnancy:
Treat chronic hypertension when BP ≥140/90 mm Hg.
Reflects evidence for tighter control to reduce maternal/fetal complications.
Resistant Hypertension:
Recommend screening for primary aldosteronism even without hypokalemia.
Continue most antihypertensives (except MRAs) during screening.

5. Emerging Therapies
Consider GLP-1 receptor agonists for patients with hypertension and obesity.

6. Monitoring
Encourage home BP monitoring.
Smartwatches and cuffless devices not yet reliable for clinical use.

🎥 2025 AHA/ACC Hypertension Guidelines: What Every Clinician Should Know
📌 Official update published in JACC on August 14, 2025

This video reviews the key updates from the 2025 Multisociety Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. What replaces traditional cardiovascular risk calculators? When should antihypertensive therapy begin? What’s new in resistant hypertension, pregnancy, and obesity?

🔍 Highlights include:
PREVENT™ risk calculator and ≥7.5% treatment threshold
Treatment initiation for Stage 1 and Stage 2 hypertension
Management in pregnancy, resistant hypertension, and obesity
Home blood pressure monitoring and device recommendations
Multidisciplinary care and social determinants of health

🎓 Designed for physicians, residents, students, and educators seeking to integrate the latest evidence into clinical practice and teaching.

📚 Based on:
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (JACC, 2025)

🔔 Subscribe for bilingual educational content on internal medicine and clinical guidelines!